Orbicular Pharmaceutical Technologies Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 25-10-2024
- Paid Up Capital ₹ 11.18 Cr
as on 25-10-2024
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 193.02 Cr
as on 25-10-2024
- Satisfied Charges ₹ 14.70 Cr
as on 25-10-2024
- Revenue -24.27%
(FY 2023)
- Profit -42.36%
(FY 2023)
- Ebitda 10.81%
(FY 2023)
- Net Worth 20.30%
(FY 2023)
- Total Assets 17.42%
(FY 2023)
About Orbicular Pharmaceutical Technologies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 11.18 Cr.
The company currently has active open charges totaling ₹193.02 Cr. The company has closed loans amounting to ₹14.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Meena Mohan, Mohan Mailtur, Hiren Patel, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24233TG2008PTC060606
- Company No.
060606
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Aug 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Orbicular Pharmaceutical Technologies Private Limited offer?
Orbicular Pharmaceutical Technologies Private Limited offers a wide range of products and services, including Corporate and Soft Skills Training, Corporate Training, Company Law & Labour Law Consultants, Statutory Compliance Services, Software Development & IT Consultant, Software Consulting Service, Urological & Obstetrics Instruments, Gynaecological Equipment.
Who are the key members and board of directors at Orbicular Pharmaceutical Technologies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Mailtur  | Managing Director | 06-Aug-2010 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meena Mohan | Director | 13-Aug-2008 | Current |
| Bhavesh Patel | Director | 01-Apr-2022 | Current |
| Hiren Patel | Director | 24-Aug-2012 | Current |
| Visalakshi Chandramouli | Nominee Director | 06-Jun-2024 | Current |
| Rahul Sudhakar | Director | 01-Jul-2019 | Current |
Financial Performance of Orbicular Pharmaceutical Technologies.
Orbicular Pharmaceutical Technologies Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.27% decrease. The company also saw a substantial fall in profitability, with a 42.36% decrease in profit. The company's net worth Soared by an impressive increase of 20.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orbicular Pharmaceutical Technologies?
In 2023, Orbicular Pharmaceutical Technologies had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Revitos Specialities Private LimitedActive 7 years 2 monthsMeena Mohan and Rahul Sudhakar are mutual person
Invitron Advanced Analytics Private LimitedActive 11 years 7 monthsMeena Mohan, Mohan Mailtur and 3 more are mutual person
Linux Laboratories Private LimitedActive 13 years 3 monthsVisalakshi Chandramouli is a mutual person
Anderson Diagnostic Services Private LimitedActive 13 years 2 monthsVisalakshi Chandramouli is a mutual person
Deeptek Medical Services Private LimitedActive 16 years 2 monthsVisalakshi Chandramouli is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 May 2024 | ₹14.00 Cr | Open |
Others Creation Date: 20 Apr 2023 | ₹11.80 Cr | Open |
Others Creation Date: 24 Nov 2022 | ₹5.50 Cr | Open |
How Many Employees Work at Orbicular Pharmaceutical Technologies?
Orbicular Pharmaceutical Technologies has a workforce of 218 employees as of Oct 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orbicular Pharmaceutical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orbicular Pharmaceutical Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
